Search

Your search keyword '"Kluth, Luis"' showing total 94 results

Search Constraints

Start Over You searched for: Author "Kluth, Luis" Remove constraint Author: "Kluth, Luis" Publisher elsevier bv Remove constraint Publisher: elsevier bv
94 results on '"Kluth, Luis"'

Search Results

1. Critical care therapy use after radical cystectomy in patients with non-metastatic bladder cancer

2. Use of inpatient palliative care in metastatic urethral cancer

3. Perioperative complications and in-hospital mortality in radical cystectomy patients with heart-valve replacement

4. Differences in other-cause mortality in metastatic renal cell carcinoma according to partial vs. radical nephrectomy and age: A propensity score matched study

5. Proposal and clinical validation of a perioperative algorithm enhancing antimicrobial stewardship in substitution urethroplasty

6. The Value of Tumour Markers in the Detection of Relapse—Lessons Learned from the Swiss Austrian German Testicular Cancer Cohort Study

9. Differences in Survival of Clear Cell Metastatic Renal Cell Carcinoma According to Partial vs. Radical Cytoreductive Nephrectomy

10. Regional differences in total hospital costs for radical cystectomy in the United States

11. Differences in long-term continence rates between prostate cancer patients with extraprostatic vs. organ-confined disease undergoing robotic-assisted radical prostatectomy: An observational studys

12. Differences in overall survival between clear cell metastatic renal cell carcinoma patients versus population-based controls according to race/ethnicity in the United States

13. Effect of Inferior Vena Cava Tumor Thrombus on Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated with Cytoreductive Nephrectomy

14. IO-IO vs IO-TKI efficacy in metastatic kidney cancer patients: A structured systematic review over time

15. Treatment patterns and rates of upgrading and upstaging in prostate cancer patients with single GGG1 positive biopsy core

16. Nomogram Predicting Downgrading in National Comprehensive Cancer Network High-risk Prostate Cancer Patients Treated with Radical Prostatectomy

17. Metastatic stage vs complications at radical nephrectomy with inferior vena cava thrombectomy

18. Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses

19. Contemporary Trends and Efficacy of Pelvic Lymph Node Dissection at Radical Cystectomy for Urothelial and Variant Histology Carcinoma of the Urinary Bladder

21. Overall Survival After Systemic Treatment in High-volume Versus Low-volume Metastatic Hormone-sensitive Prostate Cancer: Systematic Review and Network Meta-analysis

22. Feasibility and outcome of radical prostatectomy following inductive neoadjuvant therapy in patients with suspicion of rectal infiltration

23. Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer

24. Differences in Overall Survival between Clear Cell Metastatic Renal Cell Carcinoma Patients Versus Population-Based Controls According to Race/Ethnicity

25. Micropapillary Versus Urothelial Carcinoma of the Urinary Bladder: Stage at Presentation and Efficacy of Chemotherapy Across All Stages—A SEER-based Study

26. Median time to progression with TKI-based therapy after failure of immuno-oncology therapy in metastatic kidney cancer: A systematic review and meta-analysis

27. Salvage Radical Prostatectomy: Baseline Prostate Cancer Characteristics and Survival Across SEER Registries

28. Radical Cystectomy vs. Multimodality Treatment in T2N0M0 Bladder Cancer: A Population-based, Age-matched Analysis

30. The effect of race/ethnicity on histological subtype distribution, stage at presentation and cancer specific survival in urethral cancer

31. Upper Urinary Tract Tumors: Variant Histology Versus Urothelial Carcinoma

32. Sex-Related Differences Include Stage, Histology, and Survival in Urethral Cancer Patients

33. Bladder Cancer: A Comparison Between Non-urothelial Variant Histology and Urothelial Carcinoma Across All Stages and Treatment Modalities

34. Implementation of Intraoperative Frozen Section During Radical Prostatectomy: Short-term Results from a German Tertiary-care Center

35. Sex-specific Differences in the Quality of Treatment of Muscle-invasive Bladder Cancer Do Not Explain the Overall Survival Discrepancy

36. Obesity is associated with adverse short-term perioperative outcomes in patients treated with open and robot-assisted radical cystectomy for bladder cancer

38. Comparison of Complication Rates with Antibiotic Prophylaxis with Cefpodoxime Versus Fluoroquinolones After Transrectal Prostate Biopsy

39. AUTHOR REPLY

40. Impact of tumor size on the oncological outcome of high-grade nonmuscle invasive bladder cancer – examining the utility of classifying Ta bladder cancer based on size

41. Prostatic Artery Embolization versus Standard Surgical Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis

43. Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non–muscle-invasive Bladder Cancer: Results of a European Survey

45. Substitution Urethroplasty with Closure Versus Nonclosure of the Buccal Mucosa Graft Harvest Site: A Randomized Controlled Trial with a Detailed Analysis of Oral Pain and Morbidity

46. Conditional analyses of recurrence and progression in patients with TaG1 non–muscle-invasive bladder cancer

48. Impact of age on outcomes of patients with non–muscle-invasive bladder cancer treated with immediate postoperative instillation of mitomycin C

49. External Validation of the Pathologic Nodal Staging Score for Prostate Cancer: A Population-based Study

50. Comparison of the EORTC tables and the EAU categories for risk stratification of patients with nonmuscle-invasive bladder cancer

Catalog

Books, media, physical & digital resources